Logo-bi
Original Research
S Austin Richard*, Elizabeth A Frank, Cletus J M D'Souza
Bioimpacts. 2013;3(3): 119-122. doi: 10.5681/bi.2013.024
PMCID: PMC3786793     PMID: 24163803     Scopus ID: 84887326117    
PDF
XML
Cited By:
Original Research
Tayibeh Ghaffari, Mohammad Nouri, Ebrahim Irannejad, Mohammad-Reza Rashidi*
Bioimpacts. 2011;1(2): 121-128. doi: 10.5681/bi.2011.016
PMCID: PMC3648954     PMID: 23678416     Scopus ID: 84876727962    
PDF
XML
Cited By:
Original Research
Shahin Alizadeh-Fanalou ORCID, Ali Nazarizadeh ORCID, Mohammad Babaei ORCID, Mohsen Khosravi ORCID, Navid Farahmandian, Elham Bahreini* ORCID
Bioimpacts. 2020;10(3): 159-167. doi: 10.34172/bi.2020.20
PMCID: PMC7416011     PMID: 32793438     Scopus ID: 85089710918    
Glibenclamide was more effective than the highest dose of Securigera securidaca seed extract inincreasing PON1 activity, but the extract was more effective than glibenclamide in decreasing lipidperoxidation and cardiovascular risk indices.


As a peer-reviewed international open-access journal, BioImpacts publishes articles on basic and translational aspects of pharmaceutical and biomedical sciences. 
Acceptance rate: 24% 
Publication fee: Free of charge